Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on The Calmer Co International.
RELATED STOCKHEAD STORIES
Health & Biotech
Once banned in Australia, kava’s demand could go global according to ASX-listed The Calmer Co
News
ASX Earnings Wrap: Siteminder surges 20pc on solid hotel bookings; Prospa swings to loss and tanks 12pc
News
Closing Bell: ASX 200 finishes week with a red day, but at least a sand stock (PEC) is well up
News
In Case You Missed It: Lithium, Nootropics and a dash of nickel
News
Market Highlights: Earnings weigh on Wall Street; VIX falls below 14, signals ‘new bull market’
News
Top 10 at 10: Sleepy supplements, Canadian lithium, and De Grey nearology
News
Rise and Shine: Everything you need to know before the ASX opens
News
In Case You Missed It: Ecommerce expansion, nickel-copper and some gold
News
Market Highlights: Tech leads Wall Street selloff; Bitcoin touches US$30k as Powell stays on script
News
Closing Bell: ASX200 gains but small caps edge lower; Polymetals soars on thick high-grade drill results
News
Closing Bell: The end of day wrap that would have been on time if the NBN wasn’t such a smouldering sack of butt-meat
News
Top 10 at 10: More rare earths, some graphite; ambitious stock eyes one of the world’s biggest markets
News
Market Highlights: IMF trims outlook, gold could ‘go to US$1700’, and 5 ASX small caps to watch today
News
Top 10 at 10: It’s a good news day for these ASX gold, rare earths explorers
News
Rise and Shine: Everything you need to know before the ASX opens
News
CLOSING BELL: Hancock ‘wins’ the Battle for Warrego while the US endures a very long talking-to
News
